7 research outputs found
How E-Learning Is Reshaping the Education Industry of Developing Economy? An Evidence from PLS-SEM Approach
The tremendous advancement of information technology has altered the way education is delivered. Students are increasingly opting for e-learning in order to improve their academic success. Explanatory research was chosen since it is based on a well-established principle and clarifies the relationship between the independent and dependent variables. Computer self-efficacy (CSE), goal-setting (GOS), meta-cognitive strategy (METS), and online environment (ONE) are independent variables, whereas academic performance is the dependent variable (ACS). The study examined multidimensional interactions in e-learning to investigate the impact of e-learning applications on academic success. The goal of the study is to increase students' academic performance. A questionnaire was used to collect data from students, and the structural equation model (SEM) was used to prove assumptions. The positive relationship between goal setting, computer self-efficacy, metacognitive strategy, and social interaction with academic success was proposed in this study, and three of the five hypotheses were accepted. However, the finding shows that the relationship between goal setting and computer self-efficacy on academic success was insignificant. The findings of this study will assist higher education institutions in improving their e-learning methods and efforts. In addition, the research model employed helps to a better knowledge of e-learning in both theory and practice
Detail-preserving switching algorithm for the removal of random-valued impulse noise
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature. This paper presents a new algorithm for the denoising of images corrupted with random-valued impulse noise (RVIN). It employs a switching approach that identifies the noisy pixels in the first stage and then estimates their intensity values to restore them. Local statistics of the textons in distinct orientations of the sliding window are exploited to identify the corrupted pixels in an iterative manner; using an adaptive threshold range. Textons are formed by using an isometric grid of minimum local distance that preserves the texture and edge pixels of an image, effectively. At the noise filtering stage, fuzzy rules are used to obtain the noise-free pixels from the proposed tri-directional pixels to estimate the intensity values of identified corrupted pixels. The performance of the proposed denoising algorithm is evaluated on a variety of standard gray-scale images under various intensities of RVIN by comparing it with state-of-the-art denoising methods. The proposed denoising algorithm also has robust denoising and restoration power on biomedical images such as, MRI, X-Ray and CT-Scan. The extensive simulation results based on both quantitative measures and visual representations depict the superior performance of the proposed denoising algorithm for various noise intensities
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma.
Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We
aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding.
Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries.
Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the
minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and
had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were
randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical
apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to
100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a
maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h
for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to
allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients
who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable.
This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124.
Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid
(5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated
treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the
tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18).
Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and
placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein
thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of
5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98).
Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our
results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a
randomised trial
Probabilistic Modeling of Electric Vehicle Charging Pattern Associated with Residential Load for Voltage Unbalance Assessment
It has been recognized that an increased penetration of electric vehicles (EVs) may potentially alter load profile in a distribution network. As EVs are regarded as a diversely distributed load so a deterministic method, to predict EV charging load, may not account for all possible factors that could affect the power system. Thus, a stochastic approach is applied that takes into account various realistic factors such as EV battery capacity, state of charge (SOC), driving habit/need, i.e., involving type and purpose of trip, plug-in time, mileage, recharging frequency per day, charging power rate and dynamic EV charging price under controlled and uncontrolled charging schemes. A probabilistic model of EVs charging pattern associated with residential load profile is developed. The probabilistic model gives an activity based residential load profile and EV charging pattern over a period of 24 h. Then, the model output is used to assess the power quality index such as voltage unbalance factor under different electric vehicle penetration levels at different nodes of the system. An uneven EV charging scenario is identified that could cause the voltage unbalance to exceed its permissible limit
A Novel and Collaborative Network Channel Coded Mobile Communication Architecture
International audienceThis paper presents a novel algebraic framework of collaborative network channel coding scheme in a network with multiple-access relay channel. The proposed scheme helps reduce the computational complexity while enhancing energy efficiency of the wireless network. The devised scheme is intended for practical scenarios where channels exhibit various fading conditions over all the wireless links. We use network coding at the relay to give diversity boost at the receiver with lesser number of transmitted signals and lesser energy consumption. The setup demonstrates improved performance that is instrumental for the effective use of joint network channel coding (JNCC) for practical wireless networks. We further present a performance metric Energy Efficiency for the better performance evaluation
Probabilistic Modeling of Electric Vehicle Charging Pattern Associated with Residential Load for Voltage Unbalance Assessment
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
BackgroundTranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding.MethodsWe did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124.FindingsBetween July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98).InterpretationWe found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial.</div